SCHEMBL23898962

SCHEMBL23898962

CNc1ncnc2c1ccn2NC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YTHDC1 Q96MU7 2/20 0.42
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
PRMT5 O14744 3/20 0.40
WDR77 Q9BQA1 3/20 0.40
PDPK1 O15530 1/20 0.40
MAP4K4 O95819 2/20 0.38
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
EGFR P00533 1/20 0.36
SRC P12931 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
GRM1 Q13255 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18572173 0.80 ABL1 (0.54) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL22187775 0.79 PI4KA (0.43) PRMT5WDR77EGFRKDM4EMEN1
SCHEMBL22509955 0.79 PDPK1 (0.43) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL22858487 0.79 YTHDC1 (0.42) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL21473730 0.77 CCNB2 (0.43) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL22521390 0.76 YTHDC1 (0.40) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL8970970 0.69 YTHDC1 (0.66) YTHDC1PDE5APDE4APDE1APDE1B
SCHEMBL25996807 0.68 ABL1 (0.39) YTHDC1TP53LMNAPRMT5WDR77
SCHEMBL25996757 0.67 ALDH1A1 (0.38) TP53LMNAPRMT5WDR77ABL1
SCHEMBL17875203 0.67 PRMT5 (0.47) YTHDC1PRMT5WDR77ABL1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023283434-A9 AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH ALNYLAM PHARMACEUTICALS, INC. (US) 2024-03-28 WO disclosed
WO-2023069495-A1 OLIGONUCLEOTIDES WITH 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-04-27 WO disclosed
WO-2023283434-A1 AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH ALNYLAM PHARMACEUTICALS, INC. (US) 2023-01-12 WO disclosed
WO-2021202511-A2 MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF ALNYLAM PHARMACEUTICALS, INC. (US) 2021-10-07 WO disclosed